Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 6—June 2011
Research

Invasive Group A Streptococcal Infection and Vaccine Implications, Auckland, New Zealand

Atheer Safar, Diana LennonComments to Author , Joanna Stewart, Adrian Trenholme, Dragana Drinkovic, Briar Peat, Susan Taylor, Kerry Read, Sally Roberts, and Lesley Voss
Author affiliations: Author affiliations: Auckland City Hospital, Auckland, New Zealand (A. Safar, S. Roberts); The University of Auckland, Auckland (D. Lennon, J. Stewart); Kidz First Children’s Hospital/Middlemore Hospital, Auckland (A. Trenholme); North Shore Hospital, Auckland (D. Drinkovic, K. Read); The University of Auckland/Middlemore Hospital, Auckland (B. Peat); Middlemore Hospital, Auckland (S. Taylor); Starship Children’s Hospital, Auckland (L. Voss)

Main Article

Figure 1

A) Annual incidence rates for invasive group A streptococcal (GAS) disease, Auckland, New Zealand, 2005–2006. The black line indicates age-specific case-fatality rates for combined ethnicities. B) Number of invasive GAS cases among infants <24 months of age.

Figure 1. A) Annual incidence rates for invasive group A streptococcal (GAS) disease, Auckland, New Zealand, 2005–2006. The black line indicates age-specific case-fatality rates for combined ethnicities. B) Number of invasive GAS cases among infants <24 months of age.

Main Article

Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external